Excess Electron Transfer in DNA
FULL PAPER
128.0 (2C),127.9 (2C),127.8 (4C),127.6,127.0,125.9,125.4,123.8,113.2
(4C),91.2,86.7,85.5,84.0,73.2,63.7,61.4,55.2 (2C),38.9,27.1,
phases were extracted three times with ethyl acetate (50 mL). The com-
bined organic phases were dried over magnesium sulfate,filtered and the
solvent was removed under reduced pressure. The crude product was pu-
rified by flash chromatography (silica gel,50% ethyl acetate/hexanes) to
give 15 (1.420 g,86%) as a white solid. Rf =0.18 (50% ethyl acetate/hex-
anes); m.p. 2318C; 1H NMR (400 MHz,[D 6]DMSO,25 8C): d=10.48 (s,
22.7 ppm; IR (neat): n˜ = 3058,2927,1719,1677,1607,1580,1508,1444,
1413,1371,1293,1247,1200,1175,1147,1068,1051,1030,1002,951,916,
876,827,800,791,746,726,706 cm
ꢀ1;HRMS (ESI+): m/z: calcd for
C45H44N2O623Na1: 763.2995; found 763.2983 [M+Na]+.
1H),8.55 (t, 3J
4.26 (d, 3J
(H,H)=16.6 Hz,1H),3.96–3.85 (m,2H),3.61 (d,
16.6 Hz,1H),3.15–3.12 (m,1H),1.59 ppm (s,3H);
13C NMR (100 MHz,
ACHTREUNG
Oxetane phosphoramidite 2: Compound 10 (130 mg,0.17 mmol) was dis-
solved in degassed tetrahydrofuran (1 mL). After addition of diisopropy-
lethylamine (130 mL,0.74 mmol) the solution was cooled to ꢀ788C and
b-cyanoethyltetraisopropylphosphordiamidite (77 mL,0.29 mmol) was
added dropwise. The solution was allowed to warm to room temperature
and stirred for 4 h. The solvent was removed under reduced pressure.
The residue was purified by flash chromatography (deactivated silica gel,
1% methanol/chloroform + trace pyridine) to give 2 (110 mg,67%) as a
A
ACHTREUNG
CDCl3,25 8C): d=169.6,167.0,151.1,144.3,139.4,128.3 (2C),128.0
(2C),127.5,127.4,125.4 (2C),124.9 (2C),90.6,80.7,76.0,73.0,65.2,48.1,
27.9,23.0 ppm; IR (neat): n˜ = 3366,3224,3062,2872,1724,1693,1669,
1533,1492,1448,1411,1388,1369,1290,1237,1216,980,785,750,
700 cmꢀ1; MS (ESI+): m/z: 426.1 [M+Na]+,404.1 [ M+H]+; HRMS
(ESI+): m/z: calcd for C23H21N3O423Na1: 426.1430; found 426.1423
[M+Na]+.
1
yellowish film. Rf =0.29 (2% methanol/chloroform); H NMR (600 MHz,
CDCl3,25 8C): d=7.54–7.53 (m,1H),7.43–7.20 (m,15H),6.99–6.92 (m,
3J
(H,H)=5.6 Hz,6.4 Hz,1H),4.43 (s,
A
TBDMS-protected oxetane deoxyuridine conjugate 16: Compound 15
(600 mg,1.50 mmol) and DIEA (0.72 mL,4.14 mmol) were dissolved in
dry DMF (4 mL). In a second flask cuprous iodide (57 mg,0.30 mmol),
2’-deoxy-3’,5’-di-O-TBDMS-5-iodouridine (728 mg,1.25 mmol) and [Pd-
3H),6.81–6.77 (m,4H),6.10 (dd,
1H),4.23 (m,1H),4.12 (m,1H),3.72 (s,6H),3.71–3.51 (m,5H),2.96
3
2
ACHTREUNG
(dd, J
(H,H)=5.0, J
(H,H)=9.9 Hz,1H),2.69 (m,1H),2.62 (s,3H),2.58
3
2
ACHTREUNG
(t, J
(H,H)=6.2 Hz,2H),2.29 (dd, 3J
A
(H,H)=13.2 Hz,1H),
A
1.64 (s,3H),1.26–0.96 ppm (m,12H);
,
3
Both solutions were degassed by several freeze/thaw cycles then com-
bined. The resulting mixture was stirred for 12 h at room temperature.
The solution was diluted with ethyl acetate (50 mL) then washed with sa-
turated aqueous ammonium chloride (30 mL) and brine (20 mL). The
combined aqueous phases were extracted once with ethyl acetate
(30 mL). The combined organic phases were dried over magnesium sul-
fate,filtered and the solvent was removed under reduced pressure. The
crude product was purified by flash chromatography (silica gel,40% hex-
anes/ethyl acetate) to give 16 (706 mg,66%) as a yellowish solid. Rf =
0.13 (50% ethyl acetate/hexanes); m.p. 1478C (decomp); 1H NMR
(600 MHz,CDCl 3,25 8C): d=10.00 (brs,1H),8.40 (brs,1H),7.89 (s,
258C): d=169.8,158.6,151.2,144.5,143.7,138.7,135.8,135.5,130.1 (2C),
130.0 (2C),128.1 (2C),128.0 (2C),127.9 (2C),127.8 (2C),127.6,127.5,
126.9,125.9 (2C),125.4 (2C),117.5,113.1 (2C),113.0 (2C),91.2,86.4,
85.9,84.6,74.5,74.3,63.2,61.0,58.1,55.2 (2C),43.3,43.2,37.5,29.7,27.1,
24.6,24.5 (2C),22.6,20.3 ppm;
150.1,149.3 ppm; IR (neat): n˜ = 3042,2950,2922,1710,1672,1605,1574,
31P NMR (81 MHz,CDCl 3,25 8C): d=
1504,1444,1405,1362,1293,1247,1193,1131,1060,1047,1028,998,947,
912,870,821,794,791,742,720,702 cm
ꢀ1;HRMS (ESI+): m/z: calcd for
C45H61N4O923Na1P1: 963.4073; found 963.4059 [M+Na]+.
[33]
2-Thymine acetic acid benzyl ester(12)
:
Thymine 11 (5.000 g,
39.64 mmol) and potassium carbonate (5.480 g,39.65 mmol) were dis-
solved in dry DMF (120 mL). Benzyl bromoacetate (5.48 mL,
36.00 mmol) was added dropwise and the resulting mixture was stirred
for 20 h at room temperature. The suspension was filtered and the sol-
vent was removed in vacuo. The residue was treated with water
(38.5 mL) and conc. HCl (1.6 mL) and stirred for 30 min. The solid was
filtered off and dried under high vacuum,then crystallized from metha-
nol to give 12 (7.300 g,68%) as a white powder. 1H NMR (200 MHz,
[D6]DMSO,25 8C): d=11.40 (s,1H),7.52 (s,1H),7.36 (m,5H),5.18 (s,
2H),4.54 (s,2H),1.75 ppm (s,3H).
1H),7.58–7.51 (m,1H),7.29–7.09 (m,10H),6.12 (t,
3J
(H,H)=6.6 Hz,
A
1H),4.80 (s,1H),4.42 (d, (H,H)=16.3 Hz,1H),4.29–4.25 (m,1H),
3J
AHCTREUNG
4.08–3.92 (m,2H),3.86–3.82 (m,1H),3.79–3.74 (m,1H),3.66–3.61 (m,
1H),3.37–3.31 (m,1H),2.22–2.17 (m,1H),1.92–1.85 (m,1H),1.61 (s,
3H),0.81 (s,9H),0.77 (s,9H),0.01 (s,3H),0.00 (s,3H),
ꢀ0.04 (s,3H),
ꢀ0.04 ppm (s,3H); 13C NMR (150 MHz,CDCl 3,25 8C): d=169.7,167.2,
162.8,151.8,149.1,143.8,143.0,138.7,128.6 (2C),128.4 (2C),128.1,
127.9,126.0 (2C),125.3 (2C),99.0,91.1,89.3,88.4,85.9,76.4,74.7,72.1,
65.9,62.8,48.7,42.0,29.9,25.9 (3C),25.7 (3C),23.3,18.4,18.0,
ꢀ4.6,
ꢀ4.9, ꢀ5.5, ꢀ5.5 ppm; IR (neat): n˜ = 3207,3065,2952,2929,2856,1682,
1532,1463,1448,1279,1253,1205,1104,1029,968,833,777,750,
701 cmꢀ1; MS (FAB+): m/z: 880.7 [M+Na]+,858.8 [ M+H]+,536.5,514.6;
HRMS (ESI+): m/z: calcd for C44H60N5O9Si2: 858.3930; found 858.3923
[M+H]+.
Thymine acetic acid benzyl esterbenzophenone oxetane (13) :[33] Com-
pound 12 (7.000 g,25.50 mmol) was dissolved in dry acetonitrile
(650 mL) under sonication and benzophenone (9.320 g,51.90 mmol) was
added. The solution was transferred to a pyrex vessel and degassed by
sparging with argon for 30 min. Then the solution was irradiated under
argon atmosphere for 6 h with a medium pressure Hg lamp (750 W). The
solvent was removed under reduced pressure and the crude product was
purified by flash chromatography (silica gel,25% ethyl acetate/hexanes)
DMT-protected oxetane deoxyuridine conjugate 18: In a polypropylene
tube 16 (234 mg,0.27 mmol) was dissolved in EtOAc (12 mL). HF·pyri-
dine complex (Fluka,70% HF,0.1 mL,3.85 mmol) and pyridine (0.1 mL,
1.02 mmol) were added and the resulting solution was shaken for 24 h at
room temperature. The resulting suspension was treated with methoxytri-
methylsilane (0.6 mL,4.35 mmol,to destroy the excess HF) and shaken
for another two hours. The solid was collected by centrifugation and
washed twice with cold EtOAc to give crude 17. Crude 17 was dissolved
in pyridine (8 mL) and,after molecular sieves 4 and a catalytic amount
of 4-DMAP were added,stirred for 12 h at room temperature. 44, ’-Dime-
thoxytritylchloride (102 mg,0.30 mmol) was added and the mixture was
stirred for another 36 h. After removal of the solvent in vacuo the crude
product was purified by flash chromatography (silica gel,0.5% pyridine/
6% methanol/dichloromethane) to give 18 (103 mg,41%) as a colourless
oil. Rf =0.15 (silica gel,0.5% pyridine/5% methanol/dichloromethane);
1H NMR (600 MHz,[D 6]DMSO,25 8C): d=11.67 (s,1H),10.47 (s,1H),
8.57 (brs,1H),7.91 (s,1H),7.41–7.33 (m,8H),7.32–7.20 (m,11H),6.92–
6.87 (m,4H),6.12–6.07 (m,1H),5.33 (s,1H),4.77 (s,1H),4.34–4.24 (m,
2H),4.03–3.97 (m,1H),3.96–3.90 (m,2H),3.73 (s,6H),3.63–3.57 (m,
1H),3.28–3.23 (m,1H); 3.11–3.06 (m,1H),2.30–2.24 (m,1H),2.21–2.15
to give 13 (6.600 g,57%) as
[D6]DMSO,25 8C): d=10.48 (s,1H),7.20 (m,15H),5.21–4.97 (m,2H),
4.97 (s,1H),4.28 (d, 3J(H,H)=17.6 Hz,1H),4.08 (d, 3J
(H,H)=17.4 Hz,
1H),1.50 ppm (s,3H); MS (70 eV): m/z: 456.2 [M +].
a
white solid.
1H NMR (200 MHz,
A
ACHTREUNG
Thymine acetic acid benzophenone oxetane (14):[33] 13 (1.000 g,
2.20 mmol) and 10% Pd/C (100 mg,0.09 mmol) were suspended in ethyl
acetate (20 mL). The suspension was stirred under H2 atmosphere for 3 h
at atmospheric pressure. After filtration through a pad of Celite the sol-
vent was removed under reduced pressure to give 14 (790 mg,98%) as a
white solid. 1H NMR (200 MHz,[D 6]DMSO,25 8C): d=12.95 (brs,1H),
10.43 (s,1H),7.52 (s,1H),7.23 (m,10H),4.88 (s,1H),4.24 (d,
(H,H)=17.6 Hz,1H),3.85 (d, 3J
(H,H)=17.6 Hz,1H),1.57 ppm (s,3H).
Oxetane alkyne 15: HOBt (682 mg,5.04 mmol) and TBTU (1.610 g,
4.98 mmol) were added successively to solution of 14 (1.500 g,
3J-
A
ACHTREUNG
a
4.10 mmol) in dry DMF (30 mL) and the resulting mixture was stirred for
10 min at room temperature. Propargylamine (0.53 mL,8.21 mmol) and
triethylamine (3.4 mL,217.75 mmol) were added and the solution was
stirred for another 30 min. After dilution with ethyl acetate (150 mL) it
was washed three times with brine (50 mL). The combined aqueous
(m,1H),1.60 ppm (s,3H);
13C NMR (150 MHz,[D 6]DMSO,25 8C): d=
169.7,166.9,161.4,158.0 (2C),151.1,149.2,144.7,144.3,143.3,139.4,
135.5,135.1,129.6 (2C),129.5 (2C),128.3 (2C),128.0 (2C),127.8 (2C),
Chem. Eur. J. 2006, 12,6469 – 6477
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA,Weinheim
6475